According to Pharmala Biotech Holdings latest financial reports the total liabilities of MDMA is $755.83K, an increase of 142.82% to 2022. At the end of 2022 company had $311.27K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Pharmala Biotech Holdings is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $755.83K | 142.82% |
2022 | $311.27K | 206.03% |
2021 | $101.71K | - |